At July 31 exchange rates, F&P Healthcare expects first-half revenue of $1.24b and net profit of about $280m.
The first-half and full-year net profit after tax guidance incorporates $23m in US IEEPA (International Emergency Economic Powers Act) tariff refunds.
The first-half result would equate to about 14% growth in reported operating revenue and about 24% growth in net profit (excluding the impact of US tariff refunds), compared to the first half of the 2026 financial year.
The full-year outlook continues to anticipate an overall improvement in gross margin and also assumes current global tariff rates, policies and applications for the duration of this financial year, F&P Healthcare said.
The company’s annual meeting is scheduled for next Tuesday.
Stay ahead with the latest market moves, corporate updates, and economic insights by subscribing to our Business newsletter – your essential weekly round-up of all the business news you need.